Gene therapy approaches to ventricular tachyarrhythmias

Abstract Ventricular tachycardia arising from a healed myocardial infarction scar continues to be a significant cause of morbidity and mortality. Drug therapy has been inadequate to meet this challenge, and implantable devices are limited by expense and technical problems. We have proposed the use o...

Full description

Saved in:
Bibliographic Details
Published inJournal of electrocardiology Vol. 40; no. 6; pp. S187 - S191
Main Authors Donahue, J. Kevin, MD, Sasano, Tetsuo, MD, PhD, Kelemen, Kamilla, MD
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.11.2007
Elsevier Science Ltd
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Ventricular tachycardia arising from a healed myocardial infarction scar continues to be a significant cause of morbidity and mortality. Drug therapy has been inadequate to meet this challenge, and implantable devices are limited by expense and technical problems. We have proposed the use of gene therapy for cardiac arrhythmias. In this review, we present a model of postinfarct ventricular tachycardia, a method for gene delivery to this area, and results of KCNH2 -G628S gene transfer to manipulate cellular refractory properties in the arrhythmia model.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
corresponding author email: kdonahue@metrohealth.org
current address: Johns Hopkins University School of Medicine Ross 844 720 N. Rutland Ave. Baltimore, MD 21205
ISSN:0022-0736
1532-8430
DOI:10.1016/j.jelectrocard.2007.05.036